Cryptogenic stroke in women: impact of insertable cardiac monitoring in the STROKEWISE cohort study
Europace · 30.03.2026 · 28 (4)
DOI: 10.1093/europace/euag056 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Europace, online erschienen am 23.03.2026. Verfasst von Jannicke Koldéus-Falch und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Akershus University Hospital, PO Box 1000, 1478 Lørenskog, Norway. Hauptthemen laut MEDLINE: Atrial Fibrillation, Ischemic Stroke, Electrocardiography, Ambulatory, Stroke. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation Dam, Norwegian Women's Public Health Association, Norwegian Women’s Public Health Association.
Themen: Schlaganfall
Abstract (Originalsprache)
Aims
The clinical value of insertable cardiac monitoring (ICM) for detecting asymptomatic atrial fibrillation (AF) and guiding anticoagulation in patients with cryptogenic stroke remains uncertain. This study aimed to evaluate the association between ICM-detected AF and recurrent stroke, mortality, and major bleeding in women. Methods and results We consecutively compared women with cryptogenic stroke who received an ICM at Akershus University Hospital (2016–23), with a control group from Haukeland University Hospital with standard non-invasive follow-up. Participants from both hospitals had complete data in the Norwegian Stroke Registry. Primary outcomes were AF detection and recurrent stroke at 1 and 2 years; secondary outcomes included mortality, composite stroke and mortality, ischaemic cardiovascular events, oral anticoagulation initiation, and major bleeding. Multivariable logistic regression analysis was used for binary outcomes and Cox proportional hazards models for time-to-event outcomes, both adjusted for prespecified vascular risk factors. Among 475 women (mean age 73 ± 12 years; ICM n = 262), AF was detected in 36% in the ICM group vs. 9% in in the control group (OR 6.9, 95% CI 3.7–13.5; P < 0.001). No significant differences were observed in recurrent stroke (HR 1.8, 95% CI 0.78–4.36; P = 0.17), mortality (HR 0.88, 95% CI 0.58–1.58; P = 0.88), or the composite outcome (HR 0.96, 95% CI 0.6–1.5; P = 0.85) with a median follow-up of 42 months (IQR 15–66). However, fixed-time analyses showed significantly lower 2-year mortality with ICM (OR 0.40, 95% CI 0.16–0.94; P = 0.036) and fewer bleeding events (OR 0.19, 95% CI 0.06–0.52; P = 0.002). Age and troponin T were consistent independent predictors of adverse outcomes.
Conclusion
ICM increased AF detection and enabled safe anticoagulation in women with acute cryptogenic stroke. Although stroke recurrence did not differ significantly, signals of lower mortality and major bleeding support prolonged monitoring to optimize secondary prevention. ClinicalTrials.gov Identifier NCT07194811, https://clinicaltrials.gov/study/NCT07194811
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Akershus University Hospital, PO Box 1000, 1478 Lørenskog, Norway.
- Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, 0318 Oslo, Norway.
- Department of Cardiology, Akershus University Hospital, Lørenskog, Norway.
- Department of Neurology, Haukeland University Hospital, Bergen, Norway.
- Health Services Research (HØKH), Akershus University Hospital, Lørenskog, Norway.
ORCID-Profile: Jannicke Koldéus-Falch, Antje Sundseth, Loreta Skrebelyte-Strøm, Halvor Næss, Ole Morten Rønning
Förderung
- Foundation Dam
- Norwegian Women's Public Health Association
- Norwegian Women’s Public Health Association
Zitieren
APA
Koldéus-Falch, J., Thommessen, B., Sundseth, A., Skrebelyte-Strøm, L., Næss, H., Truscott Thomas, O. M., & Rønning, O. M. (2026). Cryptogenic stroke in women: impact of insertable cardiac monitoring in the STROKEWISE cohort study. Europace, 28(4). https://doi.org/10.1093/europace/euag056
Vancouver
Koldéus-Falch J, Thommessen B, Sundseth A, Skrebelyte-Strøm L, Næss H, Truscott Thomas OM, et al. Cryptogenic stroke in women: impact of insertable cardiac monitoring in the STROKEWISE cohort study. Europace. 2026;28(4). doi:10.1093/europace/euag056
BibTeX
@article{KoldusFalch2026,
author = {Koldéus-Falch, Jannicke and Thommessen, Bente and Sundseth, Antje and Skrebelyte-Strøm, Loreta and Næss, Halvor and Truscott Thomas, Owen M and Rønning, Ole Morten},
title = {Cryptogenic stroke in women: impact of insertable cardiac monitoring in the STROKEWISE cohort study},
journal = {Europace},
year = {2026},
volume = {28},
number = {4},
doi = {10.1093/europace/euag056}
}
EUVIMED